CTE Research

CTE & HBOT Research Outline

Research Outline: Hyperbaric Oxygen Therapy (HBOT) in the Treatment of Chronic Traumatic Encephalopathy (CTE)

Chronic Traumatic Encephalopathy (CTE) stands as a challenging and devastating neurological condition often associated with repeated traumatic brain injuries, such as those experienced in contact sports. The search for effective treatment options for individuals suffering from CTE has led to the exploration of innovative approaches, one of which is Hyperbaric Oxygen Therapy (HBOT). This research aims to outline a comprehensive plan for investigating the potential benefits of HBOT in the treatment of CTE.

Research Objectives
The primary objectives of this research are as follows:
 To assess the efficacy of HBOT in improving neurocognitive and functional outcomes in individuals diagnosed with CTE.
 To investigate the safety and feasibility of implementing HBOT as a treatment protocol for CTE.
 To contribute valuable insights to the field of brain injury research and expand the knowledge base surrounding CTE treatment options.

Methodology Participants Selection Criteria
Participants for this study will be selected based on strict criteria:
 Confirmed Diagnosis: Participants must have a confirmed diagnosis of Chronic Traumatic Encephalopathy (CTE) through comprehensive medical records and clinical assessment.
 Informed Consent: Ethical guidelines will be adhered to, ensuring that all participants provide informed consent, acknowledging the nature, risks, and benefits of participation.

Recruitment efforts will involve collaboration with reputable medical facilities and organizations specializing in brain injury research and direct approaches to Players, families of players and player association. This collaboration will facilitate the identification and recruitment of eligible participants.

Control Group Design
A control group will be established, consisting of individuals who do not receive Hyperbaric Oxygen Therapy (HBOT) treatment. The design will ensure comparability to the treatment group, mitigating potential biases.

Randomization will be employed in the selection of control group participants to enhance the statistical validity of the study. Variables such as age and the severity of CTE symptoms will be considered to achieve balance.

HBOT Chamber Location
The dedicated HBOT chamber will be located within a recognized medical facility known for its expertise in neurological research. This choice of location ensures the availability of qualified medical staff and necessary infrastructure. It is likely that a scarcity of chamber space will require the plan to build and contract out the operation of a chamber. Initial investigations has identified an acceptable location and operator that will be based on the Gold Coast, Queensland.

The HBOT chamber will adhere to industry standards for hyperbaric oxygen therapy. It will be equipped to provide treatment sessions at controlled pressure levels, with a schedule that accommodates the research protocol.

Treatment Protocols – HBOT Sessions
 Each participant in the treatment group will undergo a prescribed number of HBOT sessions per week.
 The duration of each session, pressure levels, and intervals between sessions will be meticulously defined in the research protocol.
 Sessions will be administered by trained medical staff with expertise in hyperbaric oxygen therapy.

 Continuous monitoring of participants during HBOT sessions will be conducted to ensure their safety and well-being.
 Trained medical professionals will be present to respond promptly to any adverse events or discomfort experienced by participants.

Data Collection – Neurocognitive Measures
 A battery of neurocognitive tests will be administered to participants before and after the treatment period.
 These tests will assess various cognitive functions, including memory, attention, and executive function.
 The data from these assessments will provide insights into potential cognitive improvements.
Functional Assessments

 Functional brain imaging techniques, such as functional Magnetic Resonance Imaging (fMRI) or Positron Emission Tomography (PET) scans, will be employed to evaluate changes in brain function.

 These assessments will provide valuable information about the impact of HBOT on neural activity and connectivity.

Longitudinal Data
 Data will be collected at multiple time points throughout the study to assess the durability of treatment effects.
 This longitudinal approach will enable the observation of any long-term improvements or changes in participants’ cognitive and functional profiles.

Data Management – Storage
 Participant data will be securely stored in compliance with data protection regulations.
 Robust data storage protocols will be established to safeguard the confidentiality and privacy of participants.

 Statistical analysis will be performed using appropriate methods to evaluate the effectiveness of HBOT.
 Longitudinal data analysis will be conducted to assess changes over time.

Safety Measures
Ensuring the safety of research participants is of paramount importance throughout the study. Several measures will be implemented to safeguard their well-being:

 Continuous Monitoring: Trained medical professionals will be present during HBOT sessions to monitor participants continuously. This monitoring includes vital signs and immediate response to any discomfort or adverse events.
 Emergency Protocols: Clear and well-defined emergency protocols will be established. These protocols will outline the steps to be taken in case of unexpected medical events or emergencies, ensuring a rapid and effective response.

 Informed Consent: Participants will receive thorough information about potential risks associated with HBOT, enabling them to provide informed consent. The right to withdraw from the study at any time without penalty will be upheld.

Ethical Considerations
Ethical principles and guidelines will be rigorously adhered to throughout the research study:
 Informed Consent: Participants will receive comprehensive information about the research, including its purpose, procedures, risks, and benefits. Their consent will be obtained voluntarily and without coercion.
 Confidentiality: Participant data will be anonymized and kept confidential. Identifiable information will be securely stored, and access will be restricted to authorized personnel only.
 Ethics Committee Approval: The research study will seek ethical approval from the appropriate institutional review board (IRB) or ethics committee. The study will be conducted in compliance with all ethical regulations and standards.

Research Timeline
A well-defined research timeline is essential to ensure the smooth execution of the study:
 Recruitment Phase: Participants will be recruited over a specified period, with diligent efforts made to meet the required sample size.
 Treatment Phase: The HBOT treatment phase will be carried out according to the prescribed protocols. This phase includes the administration of treatment sessions and continuous monitoring.
 Data Collection: Neurocognitive assessments, functional imaging, and data collection will occur at predetermined intervals throughout the study.
 Data Analysis: Data analysis will be conducted after the completion of the data collection phase. This will involve statistical analysis and interpretation of the results.
 Reporting: The research findings will be analysed, summarized, and reported in a clear and comprehensive manner.

Funding and Resources
Considerations regarding budget and resources are essential for the successful execution of the research:
 Budget Planning: A budget will be allocated to cover expenses related to participant recruitment, HBOT treatment, data collection, data analysis, and reporting.
 Potential Funding Sources: Efforts will be made to secure funding for the research study. Funding sources may include GoFundMe applications Sports Codes, research grants, academic institutions, or collaborations with healthcare organizations.

Collaboration plays a significant role in enhancing the credibility and scope of this research study:
 Interdisciplinary Collaboration: Collaboration with medical experts specializing in neurology, hyperbaric medicine, and neurological imaging will enrich the research approach.
 Research Institutions: Collaboration with reputable research institutions known for their contributions to neurological studies will provide additional expertise and resources.
 Peer Review: The research findings will undergo peer review by experts in the field to ensure the highest level of scientific rigor and objectivity.

In summary, this research study aims to investigate the potential benefits of Hyperbaric Oxygen Therapy (HBOT) in the treatment of Chronic Traumatic Encephalopathy (CTE). The comprehensive research plan outlined in this report encompasses participant selection, control group design, HBOT chamber specifications, treatment protocols, data collection and management, safety measures, ethical considerations, research timeline, and budget planning. Collaboration with experts and institutions will further strengthen the research’s credibility and impact.
By adhering to rigorous ethical standards, implementing robust safety measures, and employing a meticulous research design, this study seeks to contribute valuable insights to the field of brain injury research. Ultimately, the findings from this research may shed light on the potential effectiveness of HBOT as a treatment option for individuals afflicted with CTE.